Mr. Johnson has over 30 years experience in high tech business development in both corporate and venture environments, domestically and internationally.

Mr. Johnson served as the President and COO of ParinGenix, Inc., an early-stage phamaceutical company.

Prior to joining ParinGenix, Mr. Johnson served as a partner with Academy Funds and also as Director, Business Development, for Hoechst Research & Technology, where he had 28 years experience in developing and commercializing high technology materials for health care, textile, electronic, biotechnology, sports and structural applications.  In this position he was responsible for creating technology based investment opportunities and businesses for Hoechst, a $30 billion corporation.  By using market-focused concept development along with a staged investment protocol, Mr. Johnson created a portfolio valued at $250 million.   He achieved a project success rate from concept through successful commercialization nearly three times the industry average.

Mr. Johnson has proven business and technical skills in intellectual property, strategy creation and implementation, commercial development, start-ups, customer and vendor strategic relationships, international business practices, and creation of high value businesses and investment opportunities.  He holds a degree in Chemical Engineering from Northwestern University.  He has served on the boards of directors for Waveguide Solutions, Inc., MindValve, Inc., and Nanotechnologies, Inc.